Skip to main content
JAMA Network logoLink to JAMA Network
. 2024 Jul 10;7(7):e2420970. doi: 10.1001/jamanetworkopen.2024.20970

Risks of Placental Abruption and Preterm Delivery in Patients Undergoing Assisted Reproduction

Jennifer T Zhang 1, Rachel Lee 2, Mark V Sauer 1, Cande V Ananth 1,2,3,4,5,
PMCID: PMC11238021  PMID: 38985469

This cross-sectional study examines the risks of preterm delivery associated with assisted reproduction and placental abruption alone or in combination.

Key Points

Question

Is the combination of conception by assisted reproductive technology (ART) and placental abruption associated with the risk of preterm delivery (<37 weeks’ gestation)?

Findings

In this cross-sectional study of 78 901 058 US women who delivered between 2000 and 2019, ART conception had an increased risk of placental abruption and preterm delivery compared with spontaneous conception. There was an additive risk of preterm delivery in ART conception with placental abruption compared with ART or abruption alone.

Meaning

These findings suggest that patients who conceive using ART and then develop placental abruption have a greater risk of preterm delivery, which has consequences for the neonate.

Abstract

Importance

Patients using assisted reproductive technology (ART) may need additional counseling about the increased risks of placental abruption and preterm delivery. Further investigation into the potential additive risk of ART and placental abruption is needed.

Objective

To ascertain the risk of placental abruption in patients who conceived with ART and to evaluate if placental abruption and ART conception are associated with an increased risk of preterm delivery (<37 weeks’ gestation) over and above the risks conferred by each factor alone.

Design, Setting, and Participants

This cross-sectional study used data from the National Inpatient Sample, which includes data from all-payer hospital inpatient discharges from 48 states across the US. Participants included women aged 15 to 54 years who delivered from 2000 through 2019. Data were analyzed from January 17 to April 18, 2024.

Exposures

Pregnancies conceived with ART.

Main Outcomes and Measures

Risks of placental abruption and preterm delivery in ART conception compared with spontaneous conceptions. Associations were expressed as odds ratios (ORs) and 95% CIs derived from weighted logistic regression models before and after adjusting for confounders. The relative excess risk due to interaction (RERI) of the risk of preterm delivery based on ART conception and placental abruption was also assessed.

Results

Of 78 901 058 deliveries, the mean (SD) maternal age was 27.9 (6.0) years, and 9 212 117 patients (11.7%) were Black individuals, 14 878 539 (18.9%) were Hispanic individuals, 34 899 594 (44.2%) were White individuals, and 19 910 807 (25.2%) were individuals of other races and ethnicities. Of the total hospital deliveries, 98.2% were singleton pregnancies, 68.8% were vaginal deliveries, and 52.1% were covered by private insurance. The risks of placental abruption among spontaneous and ART conceptions were 11 and 17 per 1000 hospital discharges, respectively. After adjusting for confounders, the adjusted OR (AOR) of placental abruption was 1.42 (95% CI, 1.34-1.51) in ART pregnancies compared with spontaneous conceptions, with increased odds in White women (AOR, 1.42; 95% CI, 1.31-1.53) compared with Black women (AOR, 1.16; 95% CI, 0.93-1.44). The odds of preterm delivery were significantly higher in pregnancies conceived by ART compared with spontaneous conceptions (AOR, 1.46; 95% CI, 1.42-1.51). The risk of preterm delivery increased when patients had both ART conception and placental abruption (RERI, 2.0; 95% CI, 0.5-3.5).

Conclusions and Relevance

In this cross-sectional study, patients who conceived using ART and developed placental abruption had a greater risk of preterm delivery compared with spontaneous conception without placental abruption. These findings have implications for counseling patients who seek infertility treatment and obstetrical management of ART pregnancies.

Introduction

Worldwide, assisted reproductive technology (ART) is being increasingly used for infertility treatment. The Centers for Disease Control and Prevention reported that 238 126 patients underwent 413 776 ART cycles in the US in 2021, resulting in 91 906 live births.1 As delayed childbearing and improved access to ART become more common, these numbers will likely increase. Assisted reproductive technology includes in vitro fertilization, cryopreservation of gametes or zygotes, intracytoplasmic sperm injection (ICSI), frozen embryo transfer (FET) cycles, and preimplantation genetic testing. However, pregnancies resulting from ART are associated with neonatal complications, including preterm delivery, small for gestational age (SGA) births, and neonatal and infant mortality.2,3,4 Antenatally, these pregnancies carry increased risks of placental abruption, placenta previa, preeclampsia, gestational diabetes, cesarean delivery, and short-term risks of heart disease and stroke.5,6,7,8,9,10

Placental abruption is the premature detachment of the placenta from the uterine wall before delivery.11,12 In one study, singleton pregnancies conceived with ART experienced an 83% increase in abruption compared with spontaneously conceived pregnancies.13 In another study, patients who underwent ovulation induction or used ART were 2.4 times more likely to have abruption.14 Women with abruption have an increased risk of preterm labor compared with those with premature rupture of membranes or a medical indication for preterm delivery.15 Perinatal mortality risks among births with or without placental abruption were 102.7 and 6.2 per 1000 births, respectively, which further increased at earlier gestational ages.16 Given how ART, placental abruption, and preterm delivery affect neonatal morbidity and mortality, there is limited literature on the association among these 3 entities.

The use of ART can introduce processes that are not characteristic of in vivo reproduction. For example, ART may increase the risk of placental abnormalities due to oxidative, thermal, and mechanical stresses on molecules already undergoing epigenetic remodeling.17 While the exact pathophysiologic mechanisms are unknown, these conditions may arise from a similar etiology of inadequate remodeling of spiral arteries in early pregnancy causing uteroplacental ischemia.18,19 Studies have shown the rate of preterm delivery increases as the pregnancy progresses, often due to medical indications—most commonly placental abruption, preeclampsia, and SGA birth, collectively referred to as ischemic placental disease (IPD).20 In one study,21 ART pregnancies had 4 times the risk of preterm IPD compared with pregnancies not involving ART.

Racial disparities in the development of placental abruption and access to ART contribute to inequities in obstetric and neonatal outcomes.22,23,24,25 In the US, chronic hypertension affects a greater percentage of reproductive-age Black women (15%-19%) than White women (6%-10%) or Hispanic women (3%-10%),25 which contributes to higher rates of placental abruption, preterm delivery, superimposed preeclampsia, cerebrovascular accidents, pulmonary edema, acute kidney failure, and pregnancy-related death. Hispanic women also have higher rates of placental abruption, eclampsia, preterm birth, and neonatal death compared with non-Hispanic White women despite the former having a lower risk of chronic hypertension.22 These disparities may be explained by similar differences in social determinants of health and access to care and insurance coverage.22 Fewer Black women are undergoing ART treatment despite an increasing prevalence of infertility among Black women and a decreasing prevalence of infertility among White women.26 We designed this large population-based study to determine the risk of placental abruption in relation to infertility treatment and to evaluate if exposures to both placental abruption and ART are associated with increased risk of preterm delivery (<37 weeks’ gestation) beyond the risks conferred by each factor independently and stratified by race and ethnicity.

Methods

Data were obtained from the National Inpatient Sample (NIS) as part of the Healthcare Cost and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality. The NIS is the largest US database of inpatient hospital stays from all HCUP-participating hospitals (28 states and 994 hospitals in 2000), with more states and hospitals participating in HCUP over time (48 states plus the District of Columbia and 4568 hospitals in 2019). The NIS encompasses 98% of the US population and accounts for 7 to 8 million unweighted hospital discharges and 36 to 39 million weighted hospital discharges each year. This cross-sectional study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline27 and, in accordance with 45 CFR §46, was deemed exempt from institutional review board review and the informed consent requirement because data used in the study were deidentified.

Statistically weighted discharge data, estimated within each stratum defined by hospital characteristics—census division, rural vs urban location, hospital bed size, teaching status, and hospital ownership—were provided by the NIS for calculating national estimates. The NIS reports data with diagnosis and procedure codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) (from 2000 through third quarter 2015) and International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) (from fourth quarter 2015 through 2019) coding system, which enabled us to determine hospitalized deliveries, ART procedures, placental abruption, and preterm delivery (eTable 1 in Supplement 1). The cohort consisted of women aged 15 to 54 years who delivered in the hospital from 2000 through 2019 regardless of delivery outcome (live birth or stillbirth) and plurality (singleton or multiple births).

The HCUP provided a uniform code for race and ethnicity based on original data from HCUP partner organizations. In the NIS, race and ethnicity were coded as Asian or Pacific Islander, Black, Hispanic, Native American, White, or other (not defined in the NIS dataset), and ethnicity took precedence over race. For example, a patient who was Hispanic and Black was assigned to the category of Hispanic.28 We evaluated 4 categories of race and ethnicity: Black, Hispanic, White, and other (including Asian or Pacific Islander, Native American, and other race and ethnicity).

Covariates

We adjusted for potential confounding by maternal age at delivery (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, and 45-54 years), hospital bed size (small, medium, or large) specific to the hospital’s location and teaching status,29 hospital teaching status (teaching, nonteaching, or status unknown), hospital location (rural, urban, or unknown), region (Northeast, Midwest, South, or West), race and ethnicity (Black, Hispanic, White, or other), plurality (singleton or multiple births), income quartile (low, medium-low, medium-high, high, or unknown; derived from median household income by zip code and varies over time), insurance (Medicare, Medicaid, private, self-pay, other, or unknown),30 and year of delivery. Sample weights, clustering, and stratification were used to provide nationally representative estimates.

Statistical Analysis

We estimated the overall risks of placental abruption and preterm delivery by race, plurality, age group, and income quartile among patients who conceived with ART compared with those who conceived spontaneously, as well as the risks of preterm delivery among patients with spontaneous conceptions, ART conception, and placental abruption. We fit a logistic regression model to estimate the unadjusted and confounder-adjusted odds ratios (ORs and AORs, respectively) and 95% CIs stratified by the mother’s race and ethnicity.

To estimate the biological interactions of ART conception and placental abruption with preterm delivery, we calculated the relative risk excess due to interaction (RERI) among patients with ART conception and placental abruption. The RERI describes departure from outcomes on a relative risk (RR) scale. A positive RERI implies that the number of cases attributable to 2 hazards in combination is larger than the sum of the numbers of cases that would be caused by each hazard separately.31 The formula to calculate the RERI is: RERI = RR11 – RR10 – RR01 + 1, where RRab is the RR in the group with X1 exposure status a (1 = exposed; 0 = unexposed), and X2 exposure status b (1 = exposed; 0 = unexposed) compared with the double-exposed group.32 An RERI of 0 implies no additive interaction, RERI greater than 0 implies a superadditive interaction, and RERI less than 0 implies a subadditive interaction.33

The statistical analysis was performed in SAS, version 9.4 (SAS Institute Inc). Data were analyzed from January 17 to April 18, 2024.

Results

Of the 78 901 058 hospital deliveries between 2000 and 2019, 391 780 (0.5%) of pregnancies were conceived with ART (Table 1). The mean (SD) maternal age was 27.9 (6.0) years, and 9 212 117 patients (11.7%) were Black individuals, 14 878 539 (18.9%) were Hispanic individuals, 34 899 594 (44.2%) were White individuals, and 19 910 807 (25.2%) were individuals of other races and ethnicities. Of the total hospital deliveries, 98.2% were singleton pregnancies, 68.8% were vaginal deliveries, and 52.1% were covered by private insurance. The prevalence of pregnancies conceived with ART increased from 2000 to 2019, and the rate of placental abruption in ART conceptions was about 2-fold higher than in spontaneous conceptions but declined over time (eFigure in Supplement 1).

Table 1. Distribution of Women Who Conceived by ART and Those Who Conceived Spontaneously From the National Inpatient Sample, 2000 to 2019.

Characteristics Women, No. (%)
Total delivery hospitalizations ART conception Spontaneous conception
All patients 78 901 058 (100) 391 780 (100) 78 509 278 (100)
Age at delivery, y
15-19 6 751 463 (8.6) 2013 (0.5) 6 749 449 (8.6)
20-24 18 281 716 (23.2) 22 910 (5.8) 18 258 807 (23.3)
25-29 22 000 268 (27.9) 84 224 (21.5) 21 916 044 (27.9)
30-34 19 838 243 (25.1) 141 113 (36.0) 19 697 130 (25.1)
35-39 9 796 486 (12.4) 98 579 (25.1) 9 697 907 (12.4)
40-44 2 101 349 (2.6) 34 297 (8.8) 2 067 052 (2.6)
45-54 131 534 (0.2) 8644 (2.2) 122 891 (0.2)
Maternal race and ethnicity
Black 9 212 117 (11.7) 25 471 (6.5) 9 186 646 (11.7)
Hispanic 14 878 539 (18.9) 33 318 (8.5) 14 845 220 (18.9)
White 34 899 594 (44.2) 248 204 (63.4) 34 651 391 (44.1)
Othera 19 910 807 (25.2) 84 787 (21.6) 19 826 021 (25.3)
Plurality
Singleton 77 490 952 (98.2) 336 512 (85.9) 77 154 440 (98.3)
Multiple 1 410 106 (1.8) 55 268 (14.1) 1 354 838 (1.7)
Mode of delivery
Vaginal 54 321 703 (68.8) 189 342 (48.3) 54 132 361 (69.0)
Cesarean 24 579 354 (31.2) 202 438 (51.7) 24 376 917 (31.0)
Hospital teaching status
Teaching 37 630 315 (47.7) 115 470 (29.5) 37 514 845 (47.8)
Nonteaching 41 032 773 (52.0) 275 600 (70.3) 40 757 174 (51.9)
Unknown 237 970 (0.3) 711 (0.2) 237 259 (0.3)
Hospital location
Rural 8 785 417 (11.1) 22 621 (5.8) 8 762 796 (11.2)
Urban 69 877 671 (88.6) 368 449 (94.0) 69 509 223 (88.5)
Unknown 237 970 (0.3) 711 (0.2) 237 259 (0.3)
Hospital bed sizeb
Small 10 334 292 (13.1) 56 286 (14.4) 10 278 006 (13.1)
Medium 21 872 192 (27.7) 103 889 (26.5) 21 768 303 (27.7)
Large 46 456 604 (58.9) 230 894 (58.9) 46 225 710 (58.9)
Unknown 237 970 (0.3) 711 (0.2) 237 259 (0.3)
Region
Northeast 12 910 828 (16.4) 100 286 (25.6) 12 810 542 (16.3)
Midwest 16 880 053 (21.4) 90 098 (23.0) 16 789 955 (21.4)
South 29 970 866 (38.0) 108 658 (27.7) 29 862 209 (38.0)
West 19 139 310 (24.3) 92 739 (23.7) 19 046 571 (24.3)
Family income
Low 18 863 149 (23.9) 51 207 (13.1) 18 811 942 (24.0)
Medium-low 19 098 386 (24.2) 73 684 (18.8) 19 024 702 (24.2)
Medium-high 19 226 420 (24.4) 103 790 (26.5) 19 122 630 (24.4)
High 20 491 818 (26.0) 159 723 (40.8) 20 332 096 (25.9)
Unknown 1 221 285 (1.5) 3376 (0.9) 1 217 909 (1.6)
Insurance
Medicare 464 324 (0.6) 2072 (0.5) 462 252 (0.6)
Medicaid 32 562 238 (41.4) 47 579 (12.1) 32 254 659 (41.4)
Private 41 122 695 (52.1) 327 222 (83.5) 40 795 474 (52.0)
Self-pay 2 406 605 (3.1) 4591 (1.2) 2 402 014 (3.1)
Otherc 2 213 839 (2.8) 9828 (2.5) 2 204 011 (2.8)
Unknown 131 356 (0.2) 488 (0.1) 130 868 (0.2)
Year of delivery
2000 4 044 942 (5.1) 3512 (0.9) 4 041 430 (5.1)
2001 3 948 636 (5.0) 4118 (1.1) 3 944 518 (5.0)
2002 4 105 431 (5.2) 6532 (1.7) 4 098 899 (5.2)
2003 4 028 568 (5.1) 5557 (1.4) 4 023 011 (5.1)
2004 4 186 922 (5.3) 8259 (2.1) 4 178 663 (5.3)
2005 4 174 744 (5.5) 9804 (2.5) 4 164 940 (5.3)
2006 4 243 821 (5.4) 7380 (1.9) 4 236 442 (5.4)
2007 4 501 441 (5.7) 9694 (2.5) 4 491 747 (5.7)
2008 4 193 566 (5.3) 13 204 (3.4) 4 180 362 (5.3)
2009 4 102 423 (5.2) 16 139 (4.1) 4 086 283 (5.2)
2010 3 850 536 (4.9) 18 756 (4.8) 3 831 781 (4.9)
2011 3 803 473 (4.8) 26 119 (6.7) 3 777 354 (4.8)
2012 3 759 856 (4.8) 24 060 (6.1) 3 735 796 (4.8)
2013 3 736 073 (4.7) 27 745 (7.1) 3 708 328 (4.7)
2014 3 796 470 (4.8) 33 545 (8.6) 3 762 925 (4.8)
2015 3 799 425 (4.8) 39 200 (10.0) 3 760 225 (4.8)
2016 3 756 481 (4.7) 45 240 (11.5) 3 711 241 (4.7)
2017 3 679 726 (4.6) 30 000 (7.7) 3 649 726 (4.6)
2018 3 614 469 (4.6) 29 730 (7.6) 3 584 739 (4.6)
2019 3 574 054 (4.5) 33 185 (8.5) 3 540 869 (4.5)

Abbreviation: ART, assisted reproductive technology.

a

Other includes Asian or Pacific Islander, Native American, and other (not defined in National Inpatient Sample dataset).

b

Definitions of hospital bed size vary by region, rural vs urban status, and technical status.29

c

Definition of other varies by state.30

The risks of placental abruption among spontaneous and ART conceptions are listed in Table 2. The overall risk of placental abruption in pregnancies conceived by ART was higher than that in spontaneously conceived pregnancies (17 vs 11 per 1000 births, respectively). After adjusting for confounders, the risk of placental abruption was higher in all ART pregnancies compared with spontaneous pregnancies (AOR, 1.42; 95% CI, 1.34-1.51).

Table 2. Risks of Placental Abruption by Race and Ethnicity Among Patients Stratified by ART or Spontaneous Conception, National Inpatient Sample, 2000 to 2019.

Race and ethnicity ART conception Spontaneous conception Risk difference (95% CI) per 1000 delivery hospitalizations Odds ratio (95% CI)
Total delivery hospitalizations, No. Placental abruption (risk per 1000 delivery hospitalizations) Total delivery hospitalizations, No. Placental abruption (risk per 1000 delivery hospitalizations) Unadjusted Adjusted
Overalla 391 780 6588 (17) 78 509 278 844 092 (11) 6 (5 to 7) 1.57 (1.48 to 1.68) 1.42 (1.34 to 1.51)
Blackb 25 471 456 (18) 9 186 646 135 082 (15) 3 (−1 to 1) 1.22 (0.98 to 1.52) 1.16 (0.93 to 1.44)
Hispanicb 33 318 633 (19) 14 845 220 139 716 (9) 10 (6 to 13) 2.04 (1.70 to 2.45) 1.66 (1.38 to 1.99)
Whiteb 248 204 3937 (16) 34 651 391 352 309 (10) 6 (4 to 7) 1.57 (1.48 to 1.70) 1.42 (1.31 to 1.53)
Otherb,c 84 787 1563 (18) 19 826 021 216 985 (11) 8 (5 to 10) 1.70 (1.51 to 1.91) 1.49 (1.33 to 1.68)

Abbreviation: ART, assisted reproductive technology.

a

Overall odds ratios were adjusted for year, age group, hospital bed size, hospital teaching status, location, region, maternal race and ethnicity, singleton vs multiple births, insurance, and income based on a survey logistic regression model.

b

Odds ratios by maternal race and ethnicity were adjusted for year, age group, hospital bed size, hospital teaching status, location, region, singleton vs multiple birth, insurance, and income based on a survey logistic regression model.

c

Other includes Asian or Pacific Islander, Native American, and other (not defined in National Inpatient Sample dataset).

The risks of preterm delivery among spontaneous and ART conceptions, stratified by race, are listed in Table 3. Overall, the risk of preterm delivery was greater for pregnancies conceived by ART compared with spontaneous conception (AOR, 1.46; 95% CI, 1.42-1.51).

Table 3. Risks of Preterm Delivery Associated With ART vs Spontaneous Conception and Stratified by Race and Ethnicity, National Inpatient Sample, 2000 to 2019a.

Race and ethnicity ART conception Spontaneous conception Risk difference (95% CI) per 1000 delivery hospitalizations Odds ratio (95% CI)
Total delivery hospitalizations, No. Preterm delivery (risk per 1000 delivery hospitalizations) Total delivery hospitalizations, No. Preterm delivery (risk per 1000 delivery hospitalizations) Unadjusted Adjustedb
Overall 391 780 63 724 (163) 78 509 278 6 043 032 (77) 86 (81-90) 2.33 (2.25-2.41) 1.46 (1.42-1.51)
Black 25 471 5330 (209) 9 186 646 1 026 809 (112) 98 (86-109) 2.10 (1.95-2.26) 1.51 (1.39-1.64)
Hispanic 33 318 5960 (179) 14 845 220 1 103 546 (74) 105 (95-115) 2.72 (2.54-2.91) 1.62 (1.51-1.75)
White 248 204 38 695 (156) 34 651 391 2 455 695 (71) 85 (79-91) 2.42 (2.32-2.53) 1.46 (1.41-1.52)
Otherc 84 787 13 738 (162) 19 826 021 1 456 983 (73) 89 (81-96) 2.44 (2.30-2.58) 1.42 (1.35-1.49)

Abbreviation: ART, assisted reproductive technology.

a

Preterm delivery occurred before 37 weeks’ gestation.

b

Odds ratios were adjusted for year, age group, hospital bed size, hospital teaching status, location, region, singleton vs multiple births, insurance, and income based on a survey logistic regression model (and additionally adjusted for mother’s race and ethnicity for overall associations).

c

Other includes Asian or Pacific Islander, Native American, and other (not defined in National Inpatient Sample dataset).

The risk of preterm delivery was greater in patients with both ART conception and placental abruption than in patients who experienced only 1 factor (555 per 1000 births vs 156 per 1000 births for ART conception alone and 421 per 1000 births for placental abruption alone) (Table 4). The RERI analysis showed an increase in preterm deliveries when patients had both ART conception and placental abruption (RERI, 2.0; 95% CI, 0.5-3.5) (Table 5). This association was attenuated in Black and Hispanic women.

Table 4. Preterm Delivery Risks Stratified by Race and Ethnicity Based on Conception by ART Alone, Placental Abruption Alone, or Both Factors, National Inpatient Sample, 2000 to 2019.

Race and ethnicity ART conception only Spontaneous conception Placental abruption only Both ART conception and placental abruption
Total delivery hospitalizations, No. Preterm delivery (risk per 1000 delivery hospitalizations) Total delivery hospitalizations, No. Preterm delivery (risk per 1000 delivery hospitalizations) Total pregnancies, No. Preterm delivery (risk per 1000 delivery hospitalizations) Total delivery hospitalizations, No. Preterm delivery (risk per 1000 delivery hospitalizations)
Overall 385 192 60 065 (156) 77 665 186 5 687 626 (73) 844 092 355 406 (421) 6588 3659 (555)
Black 25 015 5078 (203) 9 051 564 961 112 (106) 135 082 65 688 (486) 456 253 (554)
Hispanic 32 686 5588 (171) 14 705 504 1 044 310 (71) 139 716 59 236 (424) 633 373 (589)
White 244 267 36 506 (149) 34 299 081 2 313 037 (67) 352 309 142 658 (405) 3937 2189 (556)
Othera 83 224 12 894 (155) 19 609 036 1 369 158 (70) 216 985 87 825 (405) 1563 845 (541)

Abbreviation: ART, assisted reproductive technology.

a

Other includes Asian or Pacific Islander, Native American, and other (not defined in National Inpatient Sample dataset).

Table 5. Association of Conception by ART and Placental Abruption, Alone and in Combination, With the Risk of Preterm Delivery by Race and Ethnicity, National Inpatient Sample, 2000 to 2019a.

Race and ethnicity Odds ratio (95% CI) RERI (95% CI)
ART conception only Placental abruption only Both ART conception and placental abruption
Unadjusted Adjusteda Unadjusted Adjusteda Unadjusted Adjusteda
Overall 2.34 (2.26 to 2.42) 1.45 (1.41 to 1.50) 9.20 (9.06 to 9.35) 9.27 (9.12 to 9.42) 15.81 (14.09 to 17.73) 11.76 (10.34 to 13.38) 2.0 (0.5 to 3.5)
Black 2.14 (1.99 to 2.31) 1.52 (1.40 to 1.65) 7.97 (7.74 to 8.20) 8.14 (7.90 to 8.39) 10.47 (7.00 to 15.64) 9.10 (5.97 to 13.88) 0.4 (−3.4 to 4.3)
Hispanic 2.70 (2.52 to 2.89) 1.61 (1.50 to 1.74) 9.63 (9.34 to 9.93) 9.86 (9.55 to 10.18) 18.70 (13.03 to 26.82) 11.25 (7.63 to 16.60) 0.8 (−3.6 to 5.1)
White 2.43 (2.33 to 2.53) 1.45 (1.40 to 1.51) 9.41 (9.22 to 9.60) 9.56 (9.37 to 9.76) 17.31 (14.95 to 20.03) 12.63 (10.67 to 14.96) 2.6 (0.5 to 4.7)
Otherb 2.44 (2.30 to 2.59) 1.40 (1.33 to 1.48) 9.06 (8.77 to 9.36) 9.09 (8.81 to 9.37) 15.70 (12.53 to 19.62) 11.25 (8.59 to 14.75) 1.8 (−1.3 to 4.8)

Abbreviations: ART, assisted reproductive technology; RERI, relative excess risk due to interaction.

a

Odds ratios were adjusted for year, age group, hospital bed size, hospital teaching status, location, region, singleton vs multiple births, insurance, and income based on a survey logistic regression model (and additionally adjusted for mother’s race and ethnicity for overall associations).

b

Other includes Asian or Pacific Islander, Native American, and other (not defined in National Inpatient Sample dataset).

Results according to plurality, age group, and income are included in eTables 2 through 5 in Supplement 1. The risks of placental abruption in pregnancies conceived by ART were higher for singleton pregnancies (AOR, 1.46; 95% CI, 1.37-1.56), women aged 25 to 29 years (AOR, 1.63; 95% CI, 1.45-1.84), and in women with high incomes (AOR, 1.62; 95% CI, 1.48-1.78). Risks of preterm delivery in ART conceptions were higher in singleton pregnancies (AOR 1.62; 95% CI, 1.57-1.67), patients aged 20 to 24 years (AOR, 1.65; 95% CI, 1.51-1.79), and in women with medium to high incomes (AOR, 1.49; 95% CI, 1.42-1.56). Preterm delivery rates in pregnancies with both ART conception and placental abruption were highest in multiple-gestation pregnancies (769 per 1000 births), women aged 45 to 54 years (618 per 1000 births), and women with low to medium incomes (590 per 1000 births). The RERI for preterm delivery in pregnancies with ART conception and placental abruption was highest in singleton pregnancies (RERI, 3.8; 95% CI, 2.0-5.5), women aged 30 to 34 years (RERI, 3.7; 95% CI, 0.9-6.5), and women with low to medium incomes (RERI, 5.1; 95% CI, 0.5-9.6).

Discussion

In this large epidemiological cross-sectional study, women who conceived by ART had an increased risk of placental abruption, and women who had both ART conception and placental abruption had an increased risk of preterm delivery compared with women with only 1 of these 2 risk factors. Our study is unique, to our knowledge, in that we explored the joint contributions of ART conception and placental abruption on the risk of preterm delivery.

ART and Placental Abruption

Among preterm births, ART conception has been associated with higher rates of placental infarction after adjusting for confounding factors, such as hypertensive disorders and fetal growth restriction.34 This brings into question: are placental abnormalities due to the processes of ART itself or due to the underlying infertility? A meta-analysis35 evaluating abnormal placentation between ART conception vs spontaneous conception in patients with reduced fertility compared with a randomized population showed a smaller effect size, suggesting that decreased fertility likely contributes to placental disease. Patients with infertility may have hormonal dysfunction including hyperandrogenism, progesterone resistance, and hyperinsulinism, which appear to impair uterine placental mechanisms.36

Other studies have found that placentas in ART conceptions had increased placental thickness, suggesting placental pathology is due to ART rather than patient factors.37 Women who become pregnant via ART are exposed to supraphysiologic estradiol levels during ART cycles. Estradiol downregulates GATA3, a transcription factor expressed in trophectoderm during embryonic development, and decreased GATA3 leads to impaired trophoblast cell migration through downstream genes integral in placentation.38 Additionally, abnormal H19 methylation imprints were found in ART-derived human preimplantation embryos.39 In a mouse model, loss of H19 imprinting affected placental tissues more than embryonic tissue.40 In humans, levels of pregnancy-associated plasma protein A, a protein involved in trophoblast invasion by contributing to maternal tolerance toward the fetus, were decreased in first-trimester pregnancies conceived by ART.41 Altogether, evidence suggests an association between abnormal hormonal levels influencing epigenetics and impaired trophoblastic invasion via ART processes.

ART and Preterm Delivery

While it has been widely reported that ART is associated with an increase in the risk of preterm delivery,42 there is no consensus on what specific ART processes confer the greatest risk. In one study, the risk of preterm delivery was 1.5 times greater after ART conception compared with spontaneous conception (11.5% vs 7.7%), but there was no difference in preterm delivery rates with or without ICSI.43 In contrast, another study found an increased risk of medically indicated preterm delivery at 32 to 36 weeks’ gestation in ART pregnancies without ICSI compared with ART pregnancies in which ICSI was used (OR, 1.6; 95% CI, 1.1-2.2).44 The transfer of embryos at the blastocyst stage (day 5 or 6) is now preferred over transfer at the cleavage stage (day 3) due to increased pregnancy and decreased rates of multifetal gestation.45 Studies also suggest that blastocyst transfers and frozen-thawed transfers increase the risk of preterm delivery by 30% to 40%,46 likely due to greater in vitro manipulation.

Frozen embryo transfer has been associated with decreased rates of IPD compared with fresh embryo transfers (RR, 0.75; 95% CI, 0.59-0.97),47 which was attributable to lower rates of SGA infants (RR, 0.36; 95% CI, 0.16-0.79).47 A meta-analysis48 reported an increased risk of placental abruption in natural and programmed FET cycles (OR, 1.23; 95% CI, 0.81-1.89). However, there was an increase in IPD in stimulation cycles compared with natural cycles (OR, 1.16; 95% CI, 1.11-2.07) and an increase in preeclampsia in cycles using hormone replacement therapy vs natural cycles (OR, 4.41; 95% CI, 1.25-15.51).49 Each cycle received a similar control for ovarian hyperstimulation, so these findings were likely due to hormonal fluctuations, particularly estrogen. Ovarian hyperstimulation in ART was associated with an increased rate of placental abruption (OR, 6.31; 95% CI, 1.44-27.56).50 Again, controlled ovarian hyperstimulation is achieved with supraphysiologic levels of estrogen. Superovulation has been associated with altered gene expression in endometrial remodeling during early implantation.51

It is uncertain if the increased risks of preterm delivery associated with ART conception and placental abruption are due to ART itself or to complications resulting from ART. These technologies may directly influence placental abnormalities, epigenetic and genetic changes due to environmental manipulation, and underlying subfertility.52 One study found that manipulation of mouse embryos in vitro affected blastocyst gene expression, potential for implantation, and placental development.41 On the other hand, ART pregnancies have been associated with an adverse maternal-fetal environment,53 likely from compensatory mechanisms, which seem to have fewer implications for preterm delivery compared with fertility treatment or preterm delivery mediated by multiple gestations after ART. As single FET cycles are increasingly used that less frequently produce multiple gestations, the roles of direct factors from ART and compensatory factors from an adverse maternal-fetal environment may play a larger role. These unknown factors highlight the need for ongoing research on the mechanisms of preterm delivery, therapeutic targets, and modulating clinical practice.

We found a smaller increased risk of placental abruption in Black patients undergoing ART compared with the risk among White and Hispanic patients. The RERI analysis indicated that the risks of preterm delivery for the combination of ART conception and placental abruption were higher in preterm delivery among Black and Hispanic patients, but substantially higher among White patients. Previous epidemiological studies found that Black race was a risk factor for placental abruption.54,55,56 Preterm delivery rates may differ among races due to psychosocial stressors, epigenetic factors, and changes in placental, endothelial, and kidney biomarkers.57,58 The weathering hypothesis states that chronic exposure to social and economic disadvantage leads to an accelerated decline in physical health outcomes and can explain racial disparities in a variety of health conditions.59 Most of the literature has found worse ART outcomes in Black women compared with White women; more aggressive ovarian stimulation is required in Black women, and they have longer duration of infertility, higher body mass index, lower implantation rates, higher rates of fibroids, and higher rates of spontaneous abortion.60 Black race is a risk factor for placental abruption, and both Black race and placental abruption are risk factors for preterm delivery; yet, among preterm births, the risk of placental abruption is lower in Black women compared with White women after adjusting for socioeconomic status and medical risk factors.54 This seemingly contradictory finding suggests that other mechanisms of preterm birth may play a greater role in Black women, such as spontaneous preterm labor or premature rupture of membranes. Most patients undergoing infertility treatment are White or Asian, suggesting a racial disparity between the composition of the population receiving fertility treatment compared with the general population.61 There is a lack of data and consistent findings on ART outcomes in the Hispanic population62; some studies suggest that Hispanic women with ART conception have similar rates of pregnancy, spontaneous abortion, and live births compared with White women with ART conception.62 Hispanic women are less likely to seek or receive infertility treatment and are more likely to have preterm delivery and low-birth-weight infants after ART compared with non-Hispanic White women undergoing ART.63

Limitations

With information from an administrative database using ICD-9-CM and ICD-10-CM data, we were unable to determine the certainty of a diagnosis and in which hospitalization period it occurred. We included diagnoses of fertility testing, male factor infertility, procreative management, and female infertility but acknowledge that these ICD-9-CM and ICD-10-CM codes do not fully reflect the use of ART. Procreative management can be used as a diagnosis code for appointments that are not related to infertility. Patients with ART conception were diagnosed primarily with obstetric codes for pregnancy resulting from ART, supervision of pregnancy with a history of infertility, and complications associated with artificial fertilization. The Centers for Disease Control and Prevention estimates that 2.3% of infants born in the US are conceived using ART,64 but our study identified an overall prevalence of only 0.5%. This suggests there could be data that are unaccounted for that could have some unknown impact on our results. Our dataset did not specify which specific ART processes were used or the subcategories of each type of ART.

The NIS does not track women across years, so we were unable to account for repeated pregnancy outcomes. Owing to data limitations, we were unable to distinguish between spontaneous and clinician-initiated preterm delivery. Although we found a greater risk of preterm delivery in patients who both conceived via ART and developed placental abruption, it is unclear whether preterm delivery and placental abruption are due to the processes of ART itself or due to diseases related to infertility.

Conclusions

To our knowledge, this cross-sectional study is the first to elucidate an additive association between the combination of placental abruption and ART conception on subsequent preterm delivery, but there are still unanswered questions about the mechanisms underlying this association. Our findings underscore the importance of counseling patients undergoing the demanding process of infertility treatment on risks to their pregnancy. The adverse effects of infertility treatments are continually being researched to direct potential targeted therapies. Finally, health care practitioners need to be aware of the complex interplay of race and ethnicity on preterm delivery and neonatal outcomes among pregnancies conceived by ART.

Supplement 1.

eFigure. Prevalence of ART Deliveries and the Prevalence of Placental Abruption Among Women who Conceived by ART or Spontaneously: National Inpatient Sample, 2000-2019

eTable 1. International Classification of Diseases Codes Used in the Study

eTable 2. Risks of Placental Abruption in Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 3. Rates of Preterm Delivery (<37 Weeks’ Gestation) in Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 4. Rates of Preterm Delivery Among Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 5. Relationship Between Conception by ART and Placental Abruption, Alone and in Combination, on the Risk of Preterm Delivery, National Inpatient Sample, 2000 to 2019

Supplement 2.

Data Sharing Statement

References

  • 1.Centers for Disease Control and Prevention . 2012. assisted reproductive technology fertility clinic success rates report. Accessed November 14, 2023. https://stacks.cdc.gov/view/cdc/26477
  • 2.Pinborg A, Wennerholm UB, Bergh C. Long-term outcomes for children conceived by assisted reproductive technology. Fertil Steril. 2023;120(3, pt 1):449-456. doi: 10.1016/j.fertnstert.2023.04.022 [DOI] [PubMed] [Google Scholar]
  • 3.Farley GJ, Sauer MV, Brandt JS, Ananth CV. Singleton pregnancies conceived with infertility treatments and the risk of neonatal and infant mortality. Fertil Steril. 2021;116(6):1515-1523. doi: 10.1016/j.fertnstert.2021.08.007 [DOI] [PubMed] [Google Scholar]
  • 4.Glatthorn HN, Sauer MV, Brandt JS, Ananth CV. Infertility treatment and the risk of small for gestational age births: a population-based study in the United States. F S Rep. 2021;2(4):413-420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jain M, Singh M. Assisted Reproductive Technology (ART) Techniques. StatPearls Publishing; 2023. [PubMed] [Google Scholar]
  • 6.Sachdev D, Yamada R, Lee R, Sauer MV, Ananth CV. Risk of stroke hospitalization after infertility treatment. JAMA Netw Open. 2023;6(8):e2331470. doi: 10.1001/jamanetworkopen.2023.31470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Henriksson P. Cardiovascular problems associated with IVF therapy. J Intern Med. 2021;289(1):2-11. doi: 10.1111/joim.13136 [DOI] [PubMed] [Google Scholar]
  • 8.Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021;21(1):449. doi: 10.1186/s12884-021-03938-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yamada R, Sachdev D, Lee R, Sauer MV, Ananth CV. Infertility treatment is associated with increased risk of postpartum hospitalization due to heart disease. J Intern Med. 2024;295(5):668-678. doi: 10.1111/joim.13773 [DOI] [PubMed] [Google Scholar]
  • 10.Sachdev D, Sauer MV, Ananth CV. Gestational diabetes mellitus in pregnancies conceived after infertility treatment: a population-based study in the United States, 2015-2020. F S Rep. 2023;5(1):102-110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brandt JS, Ananth CV. Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management. Am J Obstet Gynecol. 2023;228(5S):S1313-S1329. doi: 10.1016/j.ajog.2022.06.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Modest AM, Johnson KM, Karumanchi SA, et al. Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study. J Assist Reprod Genet. 2019;36(9):1917-1926. doi: 10.1007/s10815-019-01545-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73-85.e1, 6. doi: 10.1016/j.fertnstert.2015.09.007 [DOI] [PubMed] [Google Scholar]
  • 14.Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol. 2005;106(5, pt 1):1039-1045. doi: 10.1097/01.AOG.0000183593.24583.7c [DOI] [PubMed] [Google Scholar]
  • 15.Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH. Placental abruption and adverse perinatal outcomes. JAMA. 1999;282(17):1646-1651. doi: 10.1001/jama.282.17.1646 [DOI] [PubMed] [Google Scholar]
  • 16.Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol. 2011;174(1):99-108. doi: 10.1093/aje/kwr045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Riesche L, Bartolomei MS. Assisted reproductive technologies and the placenta: clinical, morphological, and molecular outcomes. Semin Reprod Med. 2018;36(3-04):240-248. doi: 10.1055/s-0038-1676640 [DOI] [PubMed] [Google Scholar]
  • 18.Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol. 2007;197(3):273.e1-273.e7. doi: 10.1016/j.ajog.2007.05.047 [DOI] [PubMed] [Google Scholar]
  • 19.Schur E, Baumfeld Y, Rotem R, Weintraub AY, Pariente G. Placental abruption: assessing trends in risk factors over time. Arch Gynecol Obstet. 2022;306(5):1547-1554. doi: 10.1007/s00404-022-06638-6 [DOI] [PubMed] [Google Scholar]
  • 20.Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557-1563. doi: 10.1016/j.ajog.2006.05.021 [DOI] [PubMed] [Google Scholar]
  • 21.Johnson KM, Hacker MR, Thornton K, Young BC, Modest AM. Association between in vitro fertilization and ischemic placental disease by gestational age. Fertil Steril. 2020;114(3):579-586. doi: 10.1016/j.fertnstert.2020.04.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stearns K, Tsaih SW, Palatnik A. Racial and ethnic disparities in maternal and neonatal outcomes among women with chronic hypertension. Am J Perinatol. 2022;39(10):1033-1041. doi: 10.1055/a-1745-2902 [DOI] [PubMed] [Google Scholar]
  • 23.Ghosh G, Grewal J, Männistö T, et al. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis. 2014;24(3):283-289. [PMC free article] [PubMed] [Google Scholar]
  • 24.Premkumar A, Henry DE, Moghadassi M, Nakagawa S, Norton ME. The interaction between maternal race/ethnicity and chronic hypertension on preterm birth. Am J Obstet Gynecol. 2016;215(6):787.e1-787.e8. doi: 10.1016/j.ajog.2016.08.019 [DOI] [PubMed] [Google Scholar]
  • 25.Leonard SA, Formanowski BL, Phibbs CS, et al. Chronic hypertension in pregnancy and racial-ethnic disparities in complications. Obstet Gynecol. 2023;142(4):862-871. doi: 10.1097/AOG.0000000000005342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Seifer DB, Zackula R, Grainger DA; Society for Assisted Reproductive Technology Writing Group Report . Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. Fertil Steril. 2010;93(2):626-635. doi: 10.1016/j.fertnstert.2009.02.084 [DOI] [PubMed] [Google Scholar]
  • 27.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349. doi: 10.1016/j.jclinepi.2007.11.008 [DOI] [PubMed] [Google Scholar]
  • 28.Healthcare Cost and Utilization Project . NIS Description of Data Elements: race/ethnicity of patient. Agency for Healthcare Research and Quality. Updated September 17, 2008. Accessed April 25, 2024. http://www.hcup-us.ahrq.gov/db/vars/race/nisnote.jsp
  • 29.Healthcare Cost and Utilization Project . NIS Description of Data Elements: bedsize of hospital. Agency for Healthcare Research and Quality. Updated September 17, 2008. Accessed December 6, 2023. https://hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp
  • 30.Healthcare Cost and Utilization Project . NIS Description of Data Elements: expected primary payer, uniform. Agency for Healthcare Research and Quality. Updated September 17, 2008. Accessed December 6, 2023. https://hcup-us.ahrq.gov/db/vars/pay1/nisnote.jsp
  • 31.Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol. 2009;169(6):756-760. doi: 10.1093/aje/kwn411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.de Jager DJ, de Mutsert R, Jager KJ, Zoccali C, Dekker FW. Reporting of interaction. Nephron Clin Pract. 2011;119(2):c158-c161. doi: 10.1159/000327598 [DOI] [PubMed] [Google Scholar]
  • 33.Correia K, Williams PL. Estimating the relative excess risk due to interaction in clustered-data settings. Am J Epidemiol. 2018;187(11):2470-2480. doi: 10.1093/aje/kwy154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lee KN, Song E, Lee S, et al. Association between in vitro fertilisation embryo transfer and placental pathology in women with preterm birth: a retrospective cohort study. Reprod Fertil Dev. 2022;34(18):1107-1114. doi: 10.1071/RD22184 [DOI] [PubMed] [Google Scholar]
  • 35.Vermey BG, Buchanan A, Chambers GM, et al. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? a systematic review and meta-analysis. BJOG. 2019;126(2):209-218. doi: 10.1111/1471-0528.15227 [DOI] [PubMed] [Google Scholar]
  • 36.Vannuccini S, Clifton VL, Fraser IS, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016;22(1):104-115. doi: 10.1093/humupd/dmv044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sundheimer LW, Pisarska MD. abnormal placentation associated with infertility as a marker of overall health. Semin Reprod Med. 2017;35(3):205-216. doi: 10.1055/s-0037-1603570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lee B, Kroener LL, Xu N, et al. Function and hormonal regulation of GATA3 in human first trimester placentation. Biol Reprod. 2016;95(5):113. doi: 10.1095/biolreprod.116.141861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.El Hajj N, Haaf T. Epigenetic disturbances in in vitro cultured gametes and embryos: implications for human assisted reproduction. Fertil Steril. 2013;99(3):632-641. doi: 10.1016/j.fertnstert.2012.12.044 [DOI] [PubMed] [Google Scholar]
  • 40.Rivera RM, Stein P, Weaver JR, Mager J, Schultz RM, Bartolomei MS. Manipulations of mouse embryos prior to implantation result in aberrant expression of imprinted genes on day 9.5 of development. Hum Mol Genet. 2008;17(1):1-14. doi: 10.1093/hmg/ddm280 [DOI] [PubMed] [Google Scholar]
  • 41.Choux C, Carmignac V, Bruno C, Sagot P, Vaiman D, Fauque P. The placenta: phenotypic and epigenetic modifications induced by assisted reproductive technologies throughout pregnancy. Clin Epigenetics. 2015;7(1):87. doi: 10.1186/s13148-015-0120-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sunderam S, Kissin DM, Zhang Y, et al. Assisted reproductive technology surveillance: United States, 2018. MMWR Surveill Summ. 2022;71(4):1-19. doi: 10.15585/mmwr.ss7104a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ban Frangez H, Korosec S, Verdenik I, Kotar V, Kladnik U, Vrtacnik Bokal E. Preterm delivery risk factors in singletons born after in vitro fertilization procedures. Eur J Obstet Gynecol Reprod Biol. 2014;176:183-186. doi: 10.1016/j.ejogrb.2014.03.002 [DOI] [PubMed] [Google Scholar]
  • 44.Morken NH. Preterm delivery in IVF versus ICSI singleton pregnancies: a national population-based cohort. Eur J Obstet Gynecol Reprod Biol. 2011;154(1):62-66. doi: 10.1016/j.ejogrb.2010.08.025 [DOI] [PubMed] [Google Scholar]
  • 45.Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med. 2006;354(11):1139-1146. doi: 10.1056/NEJMoa053524 [DOI] [PubMed] [Google Scholar]
  • 46.Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol. 2012;120(1):69-75. doi: 10.1097/AOG.0b013e31825b88fc [DOI] [PubMed] [Google Scholar]
  • 47.Johnson KM, Hacker MR, Resetkova N, O’Brien B, Modest AM. Risk of ischemic placental disease in fresh and frozen embryo transfer cycles. Fertil Steril. 2019;111(4):714-721. doi: 10.1016/j.fertnstert.2018.11.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zhao Z, Chen Y, Deng H, et al. The influence of embryo stage on obstetric complications and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1186068. doi: 10.3389/fendo.2023.1186068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wang Y, Chen Q, Wang Y. Effects of different endometrial preparation regimens during IVF on incidence of ischemic placental disease for FET cycles. J Clin Med. 2022;11(21):6506. doi: 10.3390/jcm11216506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ganer Herman H, Mizrachi Y, Horowitz E, et al. Obstetric outcomes following ovarian hyperstimulation syndrome in IVF - a comparison with uncomplicated fresh and frozen transfer cycles. BMC Pregnancy Childbirth. 2022;22(1):573. doi: 10.1186/s12884-022-04903-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Senapati S, Wang F, Ord T, Coutifaris C, Feng R, Mainigi M. Superovulation alters the expression of endometrial genes critical to tissue remodeling and placentation. J Assist Reprod Genet. 2018;35(10):1799-1808. doi: 10.1007/s10815-018-1244-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Fineman DC, Keller RL, Maltepe E, Rinaudo PF, Steurer MA. Fertility treatment increases the risk of preterm birth independent of multiple gestations. F S Rep. 2023;4(3):313-320. doi: 10.1016/j.xfre.2023.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Fineman DC, Keller RL, Maltepe E, Rinaudo PF, Steurer MA. Fertility treatment increases the risk of preterm birth independent of multiple gestations. F S Rep. 2023;4(3):313-320. doi: 10.1016/j.xfre.2023.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Shen TT, DeFranco EA, Stamilio DM, Chang JJ, Muglia LJ. A population-based study of race-specific risk for placental abruption. BMC Pregnancy Childbirth. 2008;8:43. doi: 10.1186/1471-2393-8-43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol. 2005;192(1):191-198. doi: 10.1016/j.ajog.2004.05.087 [DOI] [PubMed] [Google Scholar]
  • 56.Misra DP, Ananth CV. Risk factor profiles of placental abruption in first and second pregnancies: heterogeneous etiologies. J Clin Epidemiol. 1999;52(5):453-461. doi: 10.1016/S0895-4356(99)00017-7 [DOI] [PubMed] [Google Scholar]
  • 57.Kramer MR, Hogue CJ, Dunlop AL, Menon R. Preconceptional stress and racial disparities in preterm birth: an overview. Acta Obstet Gynecol Scand. 2011;90(12):1307-1316. doi: 10.1111/j.1600-0412.2011.01136.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Webster LM, Gill C, Seed PT, et al. Chronic hypertension in pregnancy: impact of ethnicity and superimposed preeclampsia on placental, endothelial, and renal biomarkers. Am J Physiol Regul Integr Comp Physiol. 2018;315(1):R36-R47. doi: 10.1152/ajpregu.00139.2017 [DOI] [PubMed] [Google Scholar]
  • 59.Forde AT, Crookes DM, Suglia SF, Demmer RT. The weathering hypothesis as an explanation for racial disparities in health: a systematic review. Ann Epidemiol. 2019;33:1-18.e3. doi: 10.1016/j.annepidem.2019.02.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Armstrong A, Plowden TC. Ethnicity and assisted reproductive technologies. Clin Pract (Lond). 2012;9(6):651-658. doi: 10.2217/cpr.12.65 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Johnston R, Fong A, Lovell S, Sobolewski PS, Rad S, Turner A. Demographic and obstetric outcomes of pregnancies conceived by assisted reproductive technology (ART) compared to non-ART pregnancies. JBRA Assist Reprod. 2015;19(1):16-20. doi: 10.5935/1518-0557.20150005 [DOI] [PubMed] [Google Scholar]
  • 62.Komorowski AS, Jain T. A review of disparities in access to infertility care and treatment outcomes among Hispanic women. Reprod Biol Endocrinol. 2022;20(1):1. doi: 10.1186/s12958-021-00875-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Fujimoto VY, Luke B, Brown MB, et al. ; Society for Assisted Reproductive Technology Writing Group . Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertil Steril. 2010;93(2):382-390. doi: 10.1016/j.fertnstert.2008.10.061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.National Centers for Chronic Disease Prevention and Health Promotion . ART success rates. Updated September 25, 2023. Accessed December 6, 2023. https://www.cdc.gov/art/artdata/

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1.

eFigure. Prevalence of ART Deliveries and the Prevalence of Placental Abruption Among Women who Conceived by ART or Spontaneously: National Inpatient Sample, 2000-2019

eTable 1. International Classification of Diseases Codes Used in the Study

eTable 2. Risks of Placental Abruption in Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 3. Rates of Preterm Delivery (<37 Weeks’ Gestation) in Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 4. Rates of Preterm Delivery Among Pregnancies Conceived by ART or Spontaneously, National Inpatient Sample, 2000 to 2019

eTable 5. Relationship Between Conception by ART and Placental Abruption, Alone and in Combination, on the Risk of Preterm Delivery, National Inpatient Sample, 2000 to 2019

Supplement 2.

Data Sharing Statement


Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES